Ann Pope
University of Oxford(GB)Cancer Research UK Clinical Trials Unit(GB)Oxford BioMedica (United Kingdom)(GB)University of Birmingham(GB)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Urinary and Genital Oncology Studies, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non–muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial(2018)139 cited
- → SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease(2023)125 cited
- → Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both(2016)88 cited
- → Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study(2021)63 cited
- → TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer(2016)54 cited